Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase EARLY_PHASE1 2Phase NA 1

Status

Recruiting 7Completed 3Unknown 1Terminated 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 4OTHER 3

Study Type

Interventional 6Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 1789Neoplasms 1516Carcinoma, Non-Small-Cell Lung 1053Prostatic Neoplasms 965Colorectal Neoplasms 889Lung Neoplasms 809Pancreatic Neoplasms 583Carcinoma, Hepatocellular 543Leukemia, Myeloid, Acute 540Stomach Neoplasms 523Ovarian Neoplasms 513Neoplasm Metastasis 492Multiple Myeloma 491Recurrence 417Melanoma 390Squamous Cell Carcinoma of Head and Neck 374Uterine Cervical Neoplasms 366Brain Neoplasms 364Head and Neck Neoplasms 355Esophageal Neoplasms 320Precursor Cell Lymphoblastic Leukemia-Lymphoma 313Endometrial Neoplasms 311Lymphoma 309Triple Negative Breast Neoplasms 301Glioblastoma 298Rectal Neoplasms 284Urinary Bladder Neoplasms 268Sarcoma 266Hematologic Neoplasms 266Colonic Neoplasms 257

Interventions

fludarabine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Recruiting × Solid Cancer × Clear all
NCT07242417 2026-01-21

TC-G203 for Patients With GPC3-Positive Advanced Solid Tumors

Beijing GoBroad Hospital

Phase EARLY_PHASE1 Recruiting
30 enrolled
Gastrointestinal

Solid Cancer

NCT07281326 2025-12-15

A Study of AK138D1 in Advanced Malignant Tumors

Akeso

Phase 1 Recruiting
200 enrolled

Solid Cancer

NCT06797037 2025-05-20

Proof of Concept to Assess the Feasibility of a Decentralised Pathway Coordinated by the Advanced Practice Nurse for Patients Receiving Oral Treatment for Cancer or Malignant Haemopathy (ACCELER PLATFORM)

Institut Claudius Regaud

Phase NA Recruiting
33 enrolled

Solid Cancer

NCT06894082 2025-03-25

Cimer

Institut Paoli-Calmettes

Recruiting
87 enrolled

Solid Cancer

NCT06730386 2025-03-06

A Phase I Study of AK138D1 in the Treatment of Advanced Solid Tumors

Akeso

Phase 1 Recruiting
100 enrolled

Solid Cancer

NCT06763159 2025-01-08

A Study of HS-20124 in Patients with Advanced Solid Tumors

Hansoh BioMedical R&D Company

Phase 1 Recruiting
450 enrolled

Solid Cancer

NCT06697665 2024-11-20

An Exploratory Clinical Study to Evaluate the Safety, Tolerability, Immune Response and Preliminary Efficacy of LM103 Injection in Combination With PD-1 in Patients With Advanced Solid Tumours

Suzhou BlueHorse Therapeutics Co., Ltd.

Phase EARLY_PHASE1 Recruiting
10 enrolled

Solid Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡